Mengjiao Jiang
Signal active
Chief Financial Officer
Bio
Mengjiao Jiang is the current Chief Financial Officer of Adcentrx Therapeutics. She previously worked at Far East Horizon Limited as a Director. Mengjiao Jiang attended Wellesley College.
Location
Shanghai, Shanghai, China, Asia
Social
Primary Organization
C-Bridge Capital
Founded
2014
Investment
15
Lead investment
9
Exits
5
Employees
101-250
Industry
Jobs history
1
Adcentrx Therapeutics
Chief Financial Officer
2024 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Mengjiao Jiang is the Chief Financial Officer at C-Bridge Capital, based in Asia. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
4
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Jun 12, 2014 | Clarus Therapeutics | Venture Round - Clarus Therapeutics | C-Bridge Capital | 31.5M |
| Jan 02, 2018 | - | Series A - CMAB BioPharm | C-Bridge Capital | 38.0M |
| Apr 02, 2018 | - | Series B - CMAB BioPharm | C-Bridge Capital | 34.0M |
| Apr 28, 2021 | Adcentrx Therapeutics | Series A - Adcentrx Therapeutics | C-Bridge Capital | 50.0M |
Clarus Therapeutics
C-Bridge CapitalExits
0
There is no exit available on this Profile
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.